Atlas Trials

A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491

Clinical trial NCT03062956 · COMPLETED

Trial details

NCT number
NCT03062956
Sponsor
MyoKardia, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dilated Cardiomyopathy
Start date
2017-01-16
Primary completion
2017-11-28
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.